Wilbanks Smith & Thomas Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.22M | Buy |
|
|||||
|
2023
Q4 | $1.19M | Hold |
|
|||||
|
2023
Q3 | $1.02M | Buy |
|
|||||
|
2023
Q2 | $1.02M | Sell |
|
|||||
|
2023
Q1 | $931K | Sell |
|
|||||
|
2022
Q4 | $855K | Sell |
|
|||||
|
2022
Q3 | $858K | Sell |
|
|||||
|
2022
Q2 | $839K | Buy |
|
|||||
|
2022
Q1 | $795K | Buy |
|
|||||
|
2021
Q4 | $635K | Sell |
|
|||||
|
2021
Q3 | $528K | Sell |
|
|||||
|
2021
Q2 | $591K | Sell |
|
|||||
|
2021
Q1 | $658K | Sell |
|
|||||
|
2020
Q4 | $753K | Buy |
|
|||||
|
2020
Q3 | $862K | Hold |
|
|||||
|
2020
Q2 | $920K | Buy |
|
|||||
|
2020
Q1 | $728K | Buy |
|
|||||
|
2019
Q4 | $626K | Hold |
|
|||||
|
2019
Q3 | $485K | Hold |
|
|||||
|
2019
Q2 | $525K | Hold |
|
|||||
|
2019
Q1 | $526K | Hold |
|
|||||
|
2018
Q4 | $474K | Hold |
|
|||||
|
2018
Q3 | $551K | Hold |
|
|||||
|
2018
Q2 | $486K | Buy |
|
|||||
|
2018
Q1 | $459K | Hold |
|
|||||
|
2017
Q4 | $422K | Sell |
|
|||||
|
2017
Q3 | $522K | Buy |
|
|||||
|
2017
Q2 | $363K | Hold |
|
|||||
|
2017
Q1 | $308K | Hold |
|
|||||
|
2016
Q4 | $207K | Hold |
|
|||||
|
2016
Q3 | $245K | Sell |
|
|||||
|
2016
Q2 | $246K | Hold |
|
|||||
|
2016
Q1 | $227K | Hold |
|
|||||
|
2015
Q4 | $359K | Hold |
|
|||||
|
2015
Q3 | $297K | Hold |
|
|||||
|
2015
Q2 | $353K | Sell |
|
|||||
|
2015
Q1 | $340K | Buy |
|
|||||
|
2014
Q4 | $337K | Buy |
|
|||||
|
2014
Q3 | $316K | Hold |
|
|||||
|
2014
Q2 | $267K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $209K | Sell |
|
|||||
|
2013
Q3 | $216K | Sell |
|
|||||
|
2013
Q2 | $229K | Buy |
|